Subscribe
shutterstock_1396958150_pavel_kapysh-2
Pavel Kapysh / Shutterstock.com
28 January 2021AmericasMuireann Bolger

FTC hits Amneal, Impax and Endo with antitrust suit

The US Federal Trade Commission is suing Endo Pharmaceuticals, Impax Laboratories, and Impax’s owner Amneal Pharmaceuticals, alleging that they were party to a 2017 agreement that violated antitrust law.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Allergan settles patent dispute with Amneal
1 September 2016   Dublin-based pharmaceutical company Allerganhas revealed that its subsidiaries, Forest Laboratories and Adamas Pharmaceuticals, have entered into a settlement agreement with Amneal Pharmaceuticals.
Americas
FTC approves Amneal’s $1.45bn acquisition of Impax
11 July 2018   The US Federal Trade Commission has issued a final approval of Amneal’s $1.45 billion acquisition of Impax.
Big Pharma
Irish pharma company prevails in US pay-for-delay case
5 July 2022   The ruling marks the latest development of a long-running dispute over the alleged delay of a generic version of the blockbuster painkiller.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Americas
Allergan settles patent dispute with Amneal
1 September 2016   Dublin-based pharmaceutical company Allerganhas revealed that its subsidiaries, Forest Laboratories and Adamas Pharmaceuticals, have entered into a settlement agreement with Amneal Pharmaceuticals.
Americas
FTC approves Amneal’s $1.45bn acquisition of Impax
11 July 2018   The US Federal Trade Commission has issued a final approval of Amneal’s $1.45 billion acquisition of Impax.
Big Pharma
Irish pharma company prevails in US pay-for-delay case
5 July 2022   The ruling marks the latest development of a long-running dispute over the alleged delay of a generic version of the blockbuster painkiller.

More on this story

Americas
Allergan settles patent dispute with Amneal
1 September 2016   Dublin-based pharmaceutical company Allerganhas revealed that its subsidiaries, Forest Laboratories and Adamas Pharmaceuticals, have entered into a settlement agreement with Amneal Pharmaceuticals.
Americas
FTC approves Amneal’s $1.45bn acquisition of Impax
11 July 2018   The US Federal Trade Commission has issued a final approval of Amneal’s $1.45 billion acquisition of Impax.
Big Pharma
Irish pharma company prevails in US pay-for-delay case
5 July 2022   The ruling marks the latest development of a long-running dispute over the alleged delay of a generic version of the blockbuster painkiller.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility